High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS.
Hematol Oncol
; 38(1): 59-66, 2020 Feb.
Article
in En
| MEDLINE
| ID: mdl-31834627
Full text:
1
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Lymphoma, T-Cell, Peripheral
/
Lymphoma, Large-Cell, Anaplastic
/
Ki-1 Antigen
/
Galectin 1
/
Anaplastic Lymphoma Kinase
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2020
Type:
Article